Gil DL, León OS, Pérez J, González I, Milián LC, Guevara M

Language: English
References: 21
Page: 175-183
PDF size: 193.55 Kb.

ABSTRACT

The redox status imbalance could be related to diverse clinical entities. Recognized analytic methodologies quantifying both: oxidative biomolecular damage and antioxidant activity were used for the characterization of redox balance in human samples (urine, lymphocytes, plasma and serum) in relation with progression markers of diverse clinical conditions. Case and control studies of Human immunodeficiency virus (HIV), Dengue, Diabetes mellitus (DM) type 1, Human-T lymphotropic virus type-1 patients and apparently healthy individuals (18-84 years) were carried out. The evaluation was also applied in intervention designs. The results evidenced oxidative alterations and antioxidant capacity decreased significantly (p < 0.05) in patients compared to healthy individuals related in age and gender. Studies of nutritional intervention and antioxidant supplementation with Vimang® in 40 and 81 HIV Cuban patients respectively showed significant beneficial changes (p < 0.05) in 56% and 43.9% of cases respectively. An observational study in 56 HIV Cuban patients was carried out involving two combinations of antiretroviral therapy. The study showed evidences of oxidative modifications significant (p < 0.05) in 87% of the cases, finding differences among combinations. An observational study involving 40 Cuban DM type 1 patients with change of neutral protamine Hagedorn insulin from pig to human recombinant, showed a significant beneficial change (p < 0.05) in 81% of the cases after the change. The integral characterization could be useful for follow up and individuals’ management but also contribute to the knowledge of the molecular mechanisms underlying in these illnesses.

REFERENCES

1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.

2. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. 2004;142(2):231-55.

3. Block G, Dietrich M, Norkus EP, Packer L. Oxidative stress in human’s populations. In: Cutler RG, Rodriguez H, editors. Critical Reviews of oxidative stress and Aging: Advances in Basic science, Diagnostic and Interventions. New Jersey: World Scientific Publishing Inc.; 2003. p. 870-80.

4. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R18-36.

5. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11(3):298-300.

6. Mendoza-Núñez VM, Ruíz-Ramos M, Sánchez-Rodríguez MA, Retana-Ugalde R, Muñóz-Sánchez JL. Aging-related oxidative stress in healthy humans. Tohoku J Exp Med. 2007;213(3):261-8.

7. Peterhans E, Grob M, Burge T, Zanoni R. Virus-induced formation of reactive oxygen intermediates in phagocytic cells. Free Radic Res Commun. 1987;3(1-5):39-46.

8. Coaccioli S, Crapa G, Fantera M, Del Giorno R, Lavagna A, Standoli ML, et al. Oxidant/antioxidant status in patients with chronic HIV infection. Clin Ter. 2010; 161(1):55-8.

9. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4th ed. Oxford: Oxford University Press; 2007.

10. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977; 21(3):247-54.

11. FAO. CERES. Sistema automatizado para la evaluación del consumo de alimentos. Roma: FAO; 1997-2001.

12. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25(1):192-205.

13. Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998;11(10):1184-94.

14. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11.

15. Aebi H. Catalase. In Methods of enzymatic analysis. Bergmeyer HU, editor. Weinheim: Verlag Chemie; 1974. p. 673-8.

16. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161(5):2524-32.

17. Burton K. Determination of DNA concentration with diphenylamine. Methods Enzymol. 1968;12B:163-6.

18. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes. 1997;46(11):1853-8.

19. Atalay M, Bilginoglu A, Kokkola T, Oksala N, Turan B. Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity. Mol Cell Biochem. 2011;351(1-2):125-31.

20. Pérez-Matute P, Zulet MA, Martínez JA. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol. 2009;9(6):771-9.

21. Kurane I, Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large. Rev Med Virol. 2001;11(5):301-11.